Kymera Therapeutics, Inc.
P/E (Price-to-Earnings)
Price
EPS
P/E (Price-to-Earnings)
| Fiscal Year | P/E (Price-to-Earnings) | EPS | Price |
|---|---|---|---|
| Sep 2021 | 4.87x | $4.35 | $21.16 |
P/E (Price-to-Earnings)
Price
EPS
P/E (Price-to-Earnings)
| Fiscal Year | P/E (Price-to-Earnings) | EPS | Price |
|---|---|---|---|
| Sep 2021 | 4.87x | $4.35 | $21.16 |